TY - JOUR
T1 - Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia-reperfusion injury
AU - Squadrito, Francesco
AU - Altavilla, Domenica
AU - Squadrito, Giovanni
AU - Saitta, Antonino
AU - Deodato, Barbara
AU - Arlotta, Mariarita
AU - Minutoli, Letteria
AU - Quartarone, Cristina
AU - Ferlito, Marcella
AU - Caputi, Achille P.
PY - 2000/1/1
Y1 - 2000/1/1
N2 - Intercellular adhesion molecule-1 (ICAM-1) plays an important role in the pathogenesis of either human and experimental myocardial ischaemia. Tacrolimus, formerly known as FK506, has been previously shown to display cardioprotective effects on experimental ischaemia/reperfusion-induced myocardial damage. This study investigated whether cardioprotection induced by tacrolimus in myocardial ischaemia-reperfusion (MI/R) injury might be due to inhibition of the nuclear factor kappa B (NF-κB) that in turn causes reduced cardiac ICAM-1 expression and blunted polymorphonuclear leukocyte accumulation. Anaesthetized rats were subjected to total occlusion (45 min) of the left main coronary artery followed by 5 h reperfusion (MI/R). Sham myocardial ischaemia-reperfusion rats (Sham MI/R) were used as controls. Myocardial necrosis, myocardial myeloperoxidase activity, serum creatine kinase (CK) activity, cardiac mRNA for ICAM-1 reverse-transcriptase polymerase chain reaction, the inhibitory protein of NF-κB IκBα (Western blot analysis) in the myocardium-at-risk, and left ventricle dP/dt(max) were evaluated. Myocardial ischaemia plus reperfusion in untreated rats produced marked myocardial necrosis, increased serum CK activity and myeloperoxidase activity (MPO, a marker of leukocyte accumulation) both in the area at risk and in the necrotic area, and reduced the left ventricle dP/dt(max). Furthermore, inhibitory protein IκBα levels decreased, and cardiac mRNA for ICAM-1 increased, after 0.5 and 5 h of reperfusion, respectively. Administration of tacrolimus (25. 50 and 100 μg/kg as an i.v, infusion 5 min after reperfusion) lowered myocardial necrosis and myeloperoxidase activity in the area at risk and in necrotic area, decreased serum CK activity, increased left ventricle dP/dt(max), reduced the loss the of inhibitory protein IκBα and blunted the message for ICAM-1. The present data suggest that tacrolimus blocks the early activation of the transcription factor NF-κB, suppresses ICAM-1 gene activation, reduces leukocyte accumulation and protects against myocardial ischaemia-reperfusion injury. (C) 2000 Academic Press.
AB - Intercellular adhesion molecule-1 (ICAM-1) plays an important role in the pathogenesis of either human and experimental myocardial ischaemia. Tacrolimus, formerly known as FK506, has been previously shown to display cardioprotective effects on experimental ischaemia/reperfusion-induced myocardial damage. This study investigated whether cardioprotection induced by tacrolimus in myocardial ischaemia-reperfusion (MI/R) injury might be due to inhibition of the nuclear factor kappa B (NF-κB) that in turn causes reduced cardiac ICAM-1 expression and blunted polymorphonuclear leukocyte accumulation. Anaesthetized rats were subjected to total occlusion (45 min) of the left main coronary artery followed by 5 h reperfusion (MI/R). Sham myocardial ischaemia-reperfusion rats (Sham MI/R) were used as controls. Myocardial necrosis, myocardial myeloperoxidase activity, serum creatine kinase (CK) activity, cardiac mRNA for ICAM-1 reverse-transcriptase polymerase chain reaction, the inhibitory protein of NF-κB IκBα (Western blot analysis) in the myocardium-at-risk, and left ventricle dP/dt(max) were evaluated. Myocardial ischaemia plus reperfusion in untreated rats produced marked myocardial necrosis, increased serum CK activity and myeloperoxidase activity (MPO, a marker of leukocyte accumulation) both in the area at risk and in the necrotic area, and reduced the left ventricle dP/dt(max). Furthermore, inhibitory protein IκBα levels decreased, and cardiac mRNA for ICAM-1 increased, after 0.5 and 5 h of reperfusion, respectively. Administration of tacrolimus (25. 50 and 100 μg/kg as an i.v, infusion 5 min after reperfusion) lowered myocardial necrosis and myeloperoxidase activity in the area at risk and in necrotic area, decreased serum CK activity, increased left ventricle dP/dt(max), reduced the loss the of inhibitory protein IκBα and blunted the message for ICAM-1. The present data suggest that tacrolimus blocks the early activation of the transcription factor NF-κB, suppresses ICAM-1 gene activation, reduces leukocyte accumulation and protects against myocardial ischaemia-reperfusion injury. (C) 2000 Academic Press.
KW - ICAM-1
KW - Myocardial ischaemia
KW - NF-κB
KW - Tacrolimus
UR - http://www.scopus.com/inward/record.url?scp=0033844442&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033844442&partnerID=8YFLogxK
U2 - 10.1006/jmcc.1999.1089
DO - 10.1006/jmcc.1999.1089
M3 - Article
C2 - 10731442
AN - SCOPUS:0033844442
SN - 0022-2828
VL - 32
SP - 429
EP - 440
JO - Journal of Molecular and Cellular Cardiology
JF - Journal of Molecular and Cellular Cardiology
IS - 3
ER -